ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-OR92

Risk of Congenital Malformation in Newborns of Mothers with Kidney Diseases: A Retrospective Cohort Study Using National Health Insurance Service Data

Session Information

Category: Women's Health and Kidney Diseases

  • 2200 Women's Health and Kidney Diseases

Authors

  • Han, Seung hyun, Seoul National University Borame Medical Center, Seoul, Korea (the Republic of)
  • Song, Jeongin, Dongguk University Ilsan Hospital, Ilsan, Korea (the Republic of)
  • Park, Sehoon, Seoul National University Hospital, Jongno-gu, Seoul, Korea (the Republic of)
  • Lee, Hajeong, Seoul National University Hospital, Jongno-gu, Seoul, Korea (the Republic of)
Background

The risk of congenital malformations in pregnancies of mothers with kidney disease, including chronic kidney disease (CKD), end-stage kidney disease (ESKD) and kidney transplant (KT) remains unclear.

Methods

A retrospective cohort study using National Health Insurance Service (NHIS) data from 2008 to 2017 was conducted in Korea, including women who delivered during this period and their newborns. The risk of congenital malformations in women with CKD, ESKD, and KT was compared with healthy controls without diabetes or hypertension. Multivariate logistic regression models were used to assess the risk of congenital malformations.

Results

A total of 2,605,422 pregnant women and their 3,637,903 children were included in the present study. Among them, 47,166 women had kidney diseases, including CKD (n = 46,930), ESKD (n = 49), and KT (n = 187). After adjusting for age, parity, hypertension, diabetes, fetal sex, smoking, BMI, preterm birth, and preeclampsia, the KT and CKD group showed a significantly increased risk of any congenital malformations (hazard ratio [HR], 1.81; 95% confidential interval [CI], 1.31-2.45; HR, 1.20; 95% CI, 1.17-1.22, respectively). The ESKD group also tended to show an increased risk of congenital malformation (HR, 1.71; p = 0.080).

Conclusion

This large-scale, population-based study indicated that neonates born to mothers with kidney diseases, especially KT and CKD, have an increased risk of congenital malformations compared to those born to healthy mothers. This highlights the need for specialized prenatal care and monitoring to improve potential fetal malformations.